Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review

Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review

Background: Randomised phase III clinical trials represent a methodological milestone to select effective drugs against metastatic cancers. In this context, and particularly in the efficacy assessment of biologic drugs, the initial metastatic tumour burden is a strong prognostic factor. Methods: A s...

Full description

Bibliographic Details
Main Authors: Mariachiara Santorsola, Vincenzo Di Lauro, Guglielmo Nasti, Michele Caraglia, Maurizio Capuozzo, Francesco Perri, Marco Cascella, Gabriella Misso, Alessandro Ottaiano
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
tumour burden
phase III studies
non-small-cell lung cancer
breast cancer
colorectal cancer
Online Access:https://www.mdpi.com/2072-6694/14/13/3262

Internet

https://www.mdpi.com/2072-6694/14/13/3262

Similar Items